Cytogen, Inc. (KOSDAQ:217330)
South Korea
· Delayed Price · Currency is KRW 3,825.00
+15.00 (0.39%)
At close: Mar 28, 2025, 3:30 PM KST
Cytogen Revenue
In the year 2024, Cytogen had annual revenue of 10.91B KRW with 242.63% growth. Cytogen had revenue of 5.59B in the quarter ending December 31, 2024, with 548.04% growth.
Revenue
10.91B
Revenue Growth
+242.63%
P/S Ratio
7.30
Revenue / Employee
n/a
Employees
51
Market Cap
81.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.91B | 7.73B | 242.63% |
| Dec 31, 2023 | 3.18B | 2.42B | 318.57% |
| Dec 31, 2022 | 760.78M | 412.93M | 118.71% |
| Dec 31, 2021 | 347.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition